
Global payments technology provider Nuvei announced Friday, April 16, it plans to acquire Mazooma Technical Services, which deals in payments for gaming and sports wagering.
The Canadian company stated in a news release that it had reached a definitive agreement to acquire Toronto-based Mazooma for approximately US$56 million, “plus additional consideration subject to the achievement of specific performance criteria (over a maximum 3-year period from the closing date) of up to a total maximum consideration of approximately $315 million.”
According to Nuvei, roughly a quarter of the consideration will likely be paid through subordinate voting shares, with the rest to be paid in cash. The transaction still needs the approval of the Toronto Stock Exchange along with customary closing conditions and is expected to close during this year’s second quarter.
Although headquartered in Canada, Mazooma operates throughout the United States, providing account-to-account payment services for gaming and sports betting customers in several states. The company is integrated with “the majority of U.S. gaming platforms and online gaming and sports betting operators,” and expected to process more than US$2 billion of ACH total volume this year, Nuvei stated.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas